Abstract: An anode active material for a lithium secondary battery according to embodiments of the present disclosure includes composite particles including carbon-based particles including pores, and a silicon-containing coating formed on a surface of the carbon-based particles, wherein the composite particles have an equivalent porosity of 5 to 25.1%, which is defined by Equation 1 below: Equivalent ? porosity ? ( % ) = ( 1 - W c ? a ? r ? b ? o ? n D c ? a ? r ? b ? o ? n + W S ? i D Si W c ? a ? rbon + W Si D P ) * 1 ? 0 ? 0 [ Equation ? 1 ] In Equation 1, Dcarbon is a density (g/cm3) of carbon, DSi is a density (g/cm3) of silicon, DP is a density (g/cm3) of the composite particles measured by a helium (He) pycnometer, WSi is a weight (g) of silicon included in the composite particles, and Wcarbon is a weight (g) of carbon included in the composite particles.

Abstract: A notching system for an electrode sheet coated with slurry on a surface of a collector includes: an electrode unwinder from which the electrode sheet is unwound; a film unwinder from which a protective film stacked on the electrode sheet is unwound; a notching device configured to notch a non-coating portion, which is a portion that is not coated with the slurry on the electrode sheet, when provided in the state in which the protective film is stacked on the electrode sheet; and a rewinder configured to wind the notched electrode sheet. Accordingly, the problem such as the cutting and tearing of the electrode sheet and the problem of causing the scratches due to the separation of the graphite powder from the surface of the electrode sheet may be solved.

Abstract: The present invention relates to a pharmaceutical composition that efficiently increases the absorption rate of a large physiologically active substance in the body; and specifically to a pharmaceutical composition comprising: (i) a large physiologically active substance; and (ii) excipient A comprising a bile acid derivative or (iii) excipient B comprising a compound having CYP450 inhibition, an antioxidant effect, or gastrointestinal enzyme activity inhibitory effect, and a method for preparing same.

Abstract: The present invention relates to a method for stabilizing ceramide and to a cosmetic composition containing stabilized ceramide and, more specifically, to a method for homogenizing and stabilizing ceramide by self-assembling the ceramide together with ?-sitosterol, resveratrol, and allantoin which are other physiologically active substances using a microfluidic chip and a high pressure homogenizer, and to a technique for using ceramide and nanoparticles containing ?-sitosterol, resveratrol, and allantoin, which are produced by means of the stabilizing method, as a cosmetic material for skin moisturizing, anti-oxidation, skin inflammation relief, skin barrier enhancement, and skin itching relief.

Abstract: Disclosed is a continuous time linear equalizer circuit having a higher bandwidth by a plurality of filters connected to different signal paths in a T-coil circuit.

Abstract: The present disclosure relates to a method for manufacturing core-shell particles using carbon monoxide, and more particularly, to a method for manufacturing core-shell particles, the method of which a simple and fast one-pot reaction enables particle manufacturing to reduce process costs, facilitate scale-up, change various types of core and shell metals, and form a multi-layered shell by including the steps of adsorbing carbon monoxide on a transition metal for a core, and reacting carbon monoxide adsorbed on the surface of the transition metal for the core, a metal precursor for a shell, and a solvent to form particles with a core-shell structure having a reduced metal shell layer formed on a transition metal core.

Abstract: A jelly-roll electrode assembly includes first and second electrodes spaced apart from each other and helically arranged in a first direction around a winding axis of a central core of the assembly. A separator overlapping portion includes a first separator positioned adjacent an inner surface of a terminal end of the second electrode and extending in a second direction opposite the first direction toward the central core, and a second separator positioned adjacent a terminal end of the first separator and extending in the second direction opposite the first direction toward the central core. A loop portion in which the first and second separators are looped about each other in the central core to extend in the first direction around the first and second electrodes such that the second separator extends in both the first and second directions within the separator overlapping portion.

Abstract: The present invention relates to a light emitting package. A light emitting package according to an embodiment of the present invention may include a body, a light emitting diode chip, and a light transmission member. The body includes a cavity open at an tipper side thereof and may be formed of a ceramic material. The light emitting diode chip is mounted in the cavity of the body and may generate and emit UV light. The light transmission member may be disposed on top of the body to cover the cavity. In addition, the light transmission member may include a light transmission layer formed of sapphire and a light loss prevention layer formed on at least one surface of the light transmission layer. The light loss prevention layer may include a lower light loss prevention layer formed on a lower surface of the light transmission layer. The light emitting diode chip and the light transmission member may be spaced apart from each other to form a space therebetween.

Abstract: Disclosed is a molecular beam epitaxy (MBE) thin film growth apparatus. The MBE thin film growth apparatus includes a growth chamber which is connected to a vacuum pump and of which an inside is maintained in an ultra-high vacuum state, a substrate manipulator which is provided inside the growth chamber and on which a substrate is mounted, a load-lock chamber which is provided outside the growth chamber and communicates with the growth chamber and in which at least one substrate, which is mounted on the substrate manipulator, for growing a thin film is located, and a substrate transfer rod that transfers the substrate from the load-lock chamber to the growth chamber or from the growth chamber to the load-lock chamber, wherein the load-lock chamber is disposed to face the substrate manipulator and disposed collinear with a substrate transfer path of the substrate transfer rod.

Abstract: Disclosed is a light emitting diode package. According to one embodiment, the light emitting diode package includes a body and a light emitting diode chip. The body includes a substrate and a sidewall formed on the substrate and may be formed with a cavity therein. The light emitting diode chip may be mounted on the substrate in the cavity of the body. The sidewall may include multiple inner side surfaces formed to surround the cavity. The inner side surfaces of the sidewall may include adjacent inner side surfaces forming an angle of 90 degrees or more therebetween. In addition, the substrate may include an insulating base, a first interconnect pattern formed on the base, a second interconnect pattern spaced apart from the first interconnect pattern, and an insulating region disposed inside the cavity to separate the first interconnect pattern from the second interconnect pattern.

Abstract: The present invention relates to an oral pharmaceutical composition comprising (i) a biologically active material conjugate in which a biological active material is conjugated with a biotin moiety, a fatty acid moiety, or a combination thereof, and (ii) an excipient, wherein the absorption rate of the biologically active material is remarkably increased, whereby conventional drugs difficult to orally administer, such as proteins or peptides, can be administered orally.